Optimi Health Corp. (OPTH) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Optimi Health Corp. (OPTH) closed at USD 3.19 on 2026-10-15, a change of -47.5 % over the past year, with a market capitalization of USD 19.35M.

Optimi Health Corp. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Optimi Health Corp. key figures

Previous close

USD 3.19 (2026-10-15)

1-year change

-47.5 %

Market cap

USD 19.35M

Enterprise value

USD 11.42M

P/E ratio (trailing)

-2.17

P/E ratio (forward)

n/a

EPS (trailing)

-1.56

EPS (forward)

n/a

PEG ratio

n/a

Price to book

1.56

Revenue growth

-28.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.46

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Optimi Health Corp.

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Optimi Health Corp. and compare it with other stocks.